Incidence of diabetes in patients with schizophrenia: a population-based study.
作者： Jer-Hwa Hsu , I-Chia Chien , Ching-Heng Lin , Yiing-Jenq Chou , Pesus Chou
DOI: 10.1177/070674371105600105
关键词:
摘要: Objective:To detect the incidence of diabetes in patients with schizophrenia Taiwan.Methods:The National Health Research Institute provided a database 1 million random subjects for study, from which we drew sample 617 068 aged 18 years and older year 2000. Subjects who had at least one service claim during this year, primary diagnosis schizophrenia, diabetes, or prescription treatment were identified. We compared initial between general population also followed cohort 2000 to 2005.Results:The was higher than (1.46% 1.12%, respectively; OR 1.47; 95% CI 1.09 1.97) Compared population, showed group 29 years; among females; those insurance ...
sagepub.com
sci-hub.se 参考文章(38)
Gary T.C. Ko, Juliana C.N. Chan, Vincent T.F. Yeung, Chun-Chung Chow, Lynn W.W. Tsang, Clive S. Cockram, A low socio-economic status is an additional risk factor for glucose intolerance in high risk Hong Kong Chinese. European Journal of Epidemiology. ,vol. 17, pp. 289- 295 ,(2001) , 10.1023/A:1017935707807
Martina C.M. Ryan, Jogin H. Thakore, Physical consequences of schizophrenia and its treatment Life Sciences. ,vol. 71, pp. 239- 257 ,(2002) , 10.1016/S0024-3205(02)01646-6
Jonathan M. Meyer, Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. The Journal of Clinical Psychiatry. ,vol. 69, pp. 26- 36 ,(2008) , 10.4088/JCP.0908E26
Wolfgang Aichhorn, Alexandra B Whitworth, Elisabeth M Weiss, Josef Marksteiner, Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles? Drug Safety. ,vol. 29, pp. 587- 598 ,(2006) , 10.2165/00002018-200629070-00004
Emilio Sacchetti, Cesare Turrina, Giovanni Parrinello, Ovidio Brignoli, Giovanni Stefanini, Giampiero Mazzaglia, Incidence of diabetes in a general practice population: a database cohort study on the relationship with haloperidol, olanzapine, risperidone or quetiapine exposure. International Clinical Psychopharmacology. ,vol. 20, pp. 33- 37 ,(2005) , 10.1097/00004850-200501000-00007
Ruud van Winkel, Marc de Hert, Martien Wampers, Dominique Van Eyck, Linda Hanssens, Andre Scheen, Joseph Peuskens, Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder. The Journal of Clinical Psychiatry. ,vol. 69, pp. 472- 479 ,(2008) , 10.4088/JCP.V69N0320
R. Ryan, A. Newnham, K. Khunti, A. Majeed, New cases of diabetes mellitus in England and Wales, 1994-1998: Database study Public Health. ,vol. 119, pp. 892- 899 ,(2005) , 10.1016/J.PUHE.2005.03.011
Sukdeb Mukherjee, DavidB. Schnur, Ravinder Reddy, Family history of type 2 diabetes in schizophrenic patients. The Lancet. ,vol. 333, pp. 495- ,(1989) , 10.1016/S0140-6736(89)91392-5
I-CHIA CHIEN, YIING-JENQ CHOU, CHING-HENG LIN, SHIN-HUEY BIH, PESUS CHOU, HONG-JEN CHANG, Prevalence and incidence of schizophrenia among national health insurance enrollees in Taiwan, 1996–2001 Psychiatry and Clinical Neurosciences. ,vol. 58, pp. 611- 618 ,(2004) , 10.1111/J.1440-1819.2004.01311.X
F Casadebaig, A Philippe, JM Guillaud-Bataille, MF Gausset, N Quemada, JL Terra, Schizophrenic patients: physical health and access to somatic care. European Psychiatry. ,vol. 12, pp. 289- 293 ,(1997) , 10.1016/S0924-9338(97)84788-8